NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1457334914 M.D.
Verify on CMS → Scott Tetreault, M.D.
Medical Oncology Physician in Tallahassee, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
771
Medicare Part D claims · 188 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$2.0K
100 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Scott Tetreault, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 771 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 771
- Part D claims, 2024
- 77%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Scott Tetreault, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1457334914), first enumerated 11/29/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 771 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$2.0K in reported industry payments (100 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Scott Tetreault, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1457334914 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1457334914
- ENUM-LEGACY 2005
- TAX-NARROW 4,028
- MIPS-NEUTRAL 75/100
- RX-LIGHT 771
- BOOK-THIN 318 in Florida
- PHOTO-ENUM Matthew Carr, MD · 2005
Scott Tetreault, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
771 ≥ 70th percentile 70% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Scott Tetreault, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Scott Tetreault, M.D.?
CMS neutral score, not measuredPrimary specialty
Medical Oncology Physician
Medicare Part D claims
771 5% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Medical Oncology Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1457334914 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/29/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Scott Tetreault, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.0K
Largest payer
Ipsen Biopharmaceuticals, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Scott Tetreault, M.D.. To verify Scott Tetreault, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Scott Tetreault, M.D. - brand share 23.0%
Medical Oncology Physician average
23% brand-name claims vs 77% generic, on 771 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
771
Total Claims
$1.7M
Total Drug Cost
188
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,082
- Total Day Supply
- 26,008
- Brand vs Generic
- 23% brand / 77% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $30K
- Opioid Claims
- 206 (26.7% rate)
- Antibiotic Claims
- 63
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 2.82
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 23, 65-74: 94, 75-84: 58, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Scott Tetreault, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Oxycodone Hcl
Oxycodone Hcl
171 claims
- Prednisone 44
Prednisone
44 claims
- Anastrozole 36
Anastrozole
36 claims
- Eliquis 35
Eliquis
35 claims
- Exemestane 34
Exemestane
34 claims
- Acyclovir 30
Acyclovir
30 claims
- Levofloxacin 26
Levofloxacin
26 claims
- Ondansetron Odt 21
Ondansetron Odt
21 claims
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 171 |
| Prednisone | 44 |
| Anastrozole | 36 |
| Eliquis Apixaban | 35 |
| Exemestane | 34 |
| Acyclovir | 30 |
| Levofloxacin | 26 |
| Ondansetron Odt Ondansetron | 21 |
| Imbruvica Ibrutinib | 19 |
| Fluconazole | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Scott Tetreault, M.D. fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Scott Tetreault, M.D.'s 771 claims are above the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tetreault, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Tetreault.
One of 318 Medical Oncology Physician providers enrolled in Florida, 5 are shown here.
Mahmoud Abdelsalam
Gainesville, FL
Dr. Guillermo Abesada-Terk
M.D.
Stuart, FL
Dr. Patrick Acevedo
M.D.
Ocala, FL
Dr. Howard Adler
M.D.
Delray Beach, FL
Dr. Syed Ahmed
M.D.
Sebring, FL
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Scott Tetreault, M.D.'s specialty? ▼
Scott Tetreault, M.D. specializes in Medical Oncology Physician and practices in Tallahassee, Florida. Credentials: M.D..
How much does Scott Tetreault, M.D. prescribe under Medicare Part D? ▼
In 2024, Scott Tetreault, M.D. wrote 771 Medicare Part D claims totaling $1.7M in drug costs for 188 beneficiaries.
What is Scott Tetreault, M.D.'s Medicare quality score? ▼
Scott Tetreault, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Scott Tetreault, M.D. located? ▼
Scott Tetreault, M.D. is located at 1815 TUSCAN HILL DR, Tallahassee, FL, 32312. Phone: (941) 916-3399.
What is Scott Tetreault, M.D.'s NPI number? ▼
Scott Tetreault, M.D.'s National Provider Identifier (NPI) is 1457334914, issued on 11/29/2005.
Does Scott Tetreault, M.D. prescribe more brand-name or generic drugs? ▼
Scott Tetreault, M.D.'s prescribing is 23% brand-name and 77% generic drugs by claim count, with $1.7M in brand drug costs.
Does Scott Tetreault, M.D. prescribe opioids? ▼
Yes, Scott Tetreault, M.D. had 206 opioid claims in 2024 with an opioid prescribing rate of 26.7%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Scott Tetreault, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Scott Tetreault, M.D.'s most frequently prescribed drugs include Oxycodone Hcl, Prednisone, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Scott Tetreault, M.D. accept Medicare? ▼
Scott Tetreault, M.D. appears in CMS Medicare data with 771 Part D claims and 188 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Scott Tetreault, M.D.'s credentials? ▼
Scott Tetreault, M.D.'s NPI is 1457334914 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.